2023 PTAB Year in Review
- Registration Closed
A panel of highly experienced PTAB advocates will discuss some of the most significant developments in PTAB practice in 2023 and how those developments will impact future cases. They will discuss important decisions promulgated last year, including several designated precedential, as well as court treatment of PTAB decisions with implications for PTAB practice. In this discussion, you will hear what you need to know to keep your PTAB practice sharp in 2024.
Sendil Devadas
Assistant Chief IP Counsel
Corteva Agriscience
Sendil Devadas is passionate about creating IP strategy road maps for difficult to spot trends in a variety of technology areas. He builds and develops collaborative teams to execute IP strategy. Sendil received his Ph.D. from Penn State University and attended University of Illinois Chicago Law School where he graduated Cum Laude.
Joshua Goldberg
Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Joshua Goldberg, leader of Finnegan’s PTAB trials section, focuses on inter partes review (IPR), covered business method (CBM), and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and on ensuing appeals to the U.S. Court of Appeals for the Federal Circuit.
Kassandra Officer
Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Kassandra Officer focuses on patent and trade secret litigation before U.S. district courts as well as on post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). Her practice encompasses a range of technologies, with an emphasis on chemicals, pharmaceuticals, and medical devices.